ETINCEL
Telephone survey for information about electronic cigarette

Heavily involved in observing tobacco-related issues, the OFDT wanted to rapidly provide the public authorities and interested professionals with a reliable, initial estimate on the extent of the phenomenon. A survey on electronic cigarettes was conducted in late 2013, a period during which sales of tobacco by the French tobacconist‘s network and sales of treatments to help quit tobacco use were dropping.

This survey was conducted from 12 to 18 November 2013 among a sample of 2,052 individuals aged 15 to 75 years living in Metropolitan France (excluding Corsica). The survey was conducted using a database of randomised land lines stratified by region and community category. The sample selected from this database was created using the quota sampling method (gender, age category and SPC) and was called and interviewed over a one-week period. The results were weighted with the latest INSEE data.

Results

Results of the ETINCEL - OFDT electronic cigarette survey : Prevalence, purchase and use behaviours, reasons for using electronic cigarettes
Brief, February 2014

 

 

 

 

 

 

 

 

 

 

Drugs in Europe


2021 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.